Vial to Ready-To-Administer Need and BD Solution Offerings in Acute Care
Information
Several factors motivate pharmaceutical companies and hospitals to use glass pre-fillable syringes (PFS) for Intravenous (IV) applications. By switching from vials and ampules to a glass PFS, hospitals have the potential to reduce medical errors, improve workflow efficiency and impact ROI for hospital stakeholders.
Moreover, data suggests that approximately 92% of hospital stakeholders are willing to use prefilled syringes for multiple drugs.
For pharmaceutical companies, transitioning a fixed-dose drug from its vial or ampule format to a prefilled syringe can serve as a differentiation strategy in a market dominated by vials and ampules.
This session will examine the benefits and challenges associated with glass formats and will explore BD's glass pre-fillable syringe with connection performance verified for IV applications.
